Progressive Hairy Cell Leukemia Initial Treatment

specific

A hairy cell leukemia requiring initial treatment because of the presence of signs of progression. Signs of progression include cytopenia (especially if symptomatic), increasing splenomegaly, and infectious complications. Therapy is not necessary if the patients are asymptomatic and the blood counts are maintained in an acceptable range.

Centers

Active Trials

—

Cancer Funding

Top Centers for Progressive Hairy Cell Leukemia Initial Treatment(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	52.6
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	52.6
3	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	52.6
4	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive	—	—	52.6
5	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	52.6
6	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	52.6
7	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	52.6
8	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive	—	—	52.6
9	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	52.6
10	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	52.6
11	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	52.6
12	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	52.6
13	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive	—	—	52.6
14	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	—	52.6
15	University of Illinois Cancer CenterChicago, IL	—	—	52.6
16	Boston University Cancer CenterBoston, MA	—	—	52.6
17	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	—	52.6
18	Cancer Center at IllinoisUrbana, IL	—	—	52.6
19	University of Cincinnati Cancer CenterCincinnati, OH	—	—	52.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →